Skip to content
Screener

Medtronic MDT Litigation provision

Litigation provision at other companies

REX American Resources logo
REX American ResourcesREX
$0
EAT
Brinker InternationalEAT
$0-100%
Amplify Energy logo
Amplify EnergyAMPY
$12K-97.0%
Independent Bank Corporation logo
Independent Bank CorporationIBCP
$350K
Solventum logo
SolventumSOLV
$204M
Deluxe logo
DeluxeDLX
$500K

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$110.07B-3.9%
Enterprise value$137.33B-3.2%
P/E22.9×-1.6×
P/S-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:LossContingencyLossInPeriod.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions, except per share data)Fiscal Year / 2026Fiscal Year / 2025Fiscal Year / 2024
Selling, general, and administrative expense11,78410,84910,736
Amortization of intangible assets1,7721,8071,693
Restructuring charges, net249267226
Certain litigation charges, net113317149
Other operating expense (income), net386(23)464
Operating profit6,4675,9555,144
Other non-operating expense (income), net(384)(402)(412)
Interest expense, net715729719

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's litigation provision?
Medtronic (MDT) reported litigation provision of $28.25M in Q1 2026.
How has Medtronic's litigation provision changed year-over-year?
Medtronic's litigation provision decreased by 64.4% year-over-year, from $79.25M to $28.25M.
What is the long-term trend for Medtronic's litigation provision?
Over 2 years (2024 to 2026), Medtronic's litigation provision has grown at a -12.9% compound annual growth rate (CAGR), from $149M to $113M.
What does litigation provision mean?
This metric represents the net charges recognized in the income statement related to legal proceedings, settlements, or potential loss contingencies arising from the company's business operations. It reflects the financial impact of litigation, regulatory investigations, or patent disputes that are deemed probable and estimable under accounting standards. These expenses are distinct from routine operating costs and indicate potential risks associated with product liability, intellectual property, or compliance matters.

Ask your AI about Medtronic's litigation provision.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude